Be Ever Vigilant to Survive a HRSA 340B Audit

Wednesday, July 6, 2016 12:00:00 AM

The complexities of the 340B Drug Pricing Program require continual oversight and review. In this third article in our series, “5 Steps 340B Hospitals Should Take Now,” we reveal how having the right systems and procedures in place can make a tremendous difference between a successful audit and one that could result in costly repayments to manufacturers, or even losing program eligibility.

read more